Duration of Diabetes, Glycemic Control, and Risk of Heart Failure Among Adults With Diabetes: A Cohort Study

J Clin Endocrinol Metab. 2023 Apr 13;108(5):1166-1172. doi: 10.1210/clinem/dgac642.

Abstract

Context: The influences of diabetes duration and glycemic control and their potential interplays on the risk of heart failure (HF) remain unclear.

Objective: This work aimed to investigate the association of diabetes duration and glycemic control with the risk of HF.

Methods: A total of 23 754 individuals with diabetes but without HF during the baseline recruitment of UK Biobank were included in this study. Duration of diabetes was self-reported, and the status of glycemic control was reflected by glycated hemoglobin A1c (HbA1c) levels. Their associations with incident HF were assessed using multivariate Cox models adjusting for traditional risk factors.

Results: Duration of diabetes and HbA1c levels both were positively associated with the risk of HF. The hazard ratios (HRs) (95% CI) for diabetes durations of 5 to less than 10, 10 to less than 15, and 15 years or more were 1.09 (0.97-1.23), 1.13 (0.97-1.30), and 1.32 (1.15-1.53), respectively (vs < 5 years); and the HRs for HbA1c of 53.0 to less than 58.5 mmol/mol (7.0% to < 7.5%), 58.5 to less than 63.9 mmol/mol (7.5% to < 8.0%), and 63.9 mmol/mol or greater (8.0%) were 1.15 (1.02-1.31), 1.07 (0.91-1.26), and 1.46 (1.30-1.65), respectively (vs < 53.0 mmol/mol [7.0%]). Individuals with the longest disease duration (≥ 15 years) and poorer glycemic control (HbA1c ≥ 63.9 mmol/mol [8.0%]) had a particularly higher risk of HF (P for interaction = .026).

Conclusion: The risk of HF among individuals with diabetes increases with a longer duration of diabetes and increasing HbA1c levels. This finding may contribute to the individualized prevention of HF in patients with diabetes if being considered in clinical practices and policy-making.

Keywords: diabetes; duration; glycated hemoglobin; glycemic control; heart failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose
  • Cohort Studies
  • Diabetes Mellitus, Type 2* / complications
  • Glycated Hemoglobin
  • Glycemic Control
  • Heart Failure* / complications
  • Heart Failure* / etiology
  • Humans
  • Risk Factors

Substances

  • Glycated Hemoglobin
  • Blood Glucose